Gregory Reyes - 30 Jan 2026 Form 4 Insider Report for ARTELO BIOSCIENCES, INC. (ARTL)

Role
Director
Signature
/s/ Gregory D. Gorgas, as Attorney-in-Fact
Issuer symbol
ARTL
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
02 Feb 2026, 16:41:56 UTC
Previous filing
23 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Reyes Gregory Director C/O ARTELO BIOSCIENCES, INC., 505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH /s/ Gregory D. Gorgas, as Attorney-in-Fact 02 Feb 2026 0001404055

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARTL Stock Options (right to buy) Award $0 +292 $0.000000 292 30 Jan 2026 Common Stock 292 $1.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's Plan) through each such applicable vesting date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Vesting Commencement Date, or (ii) the day prior to the date of the annual meeting of the Issuer's stockholders next following the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 30, 2026.